CD4 and melanoma: Of note, the rare CD4+BRAFV600E-specific T cells reported in the acral melanoma patient by Veatch et al. were not paralleled by BRAFV600E-specific CD8+ T cells, but by diverse CD8+ T cells reactive to multiple melanoma-associated self-antigens.